Amid the current situation in Israel, IMP Services remains steadfast in our commitment to support and provide innovative solutions for your clinical trial logistics. Our goal is to ensure seamless operations for your trials, tailored to meet your unique needs.
We’re pleased to share the recent update from the Israeli Ministry of Health. This letter emphasizes the MoH’s dedication to supporting ongoing and new clinical trials despite the current challenges. It stresses the importance of maintaining stability and adherence to regulatory frameworks, ensuring the continuity of critical trials.
Our team and facility are fully operational, supporting importation services without disruption. Hospitals conducting clinical trials in Israel have confirmed the continuation of trials, maintaining necessary infrastructure and operational processes.
We remain committed to keeping you updated on any further developments in the coming weeks. Your continuous support and partnership are deeply appreciated.

Share this article
Blog
Navigating the Clinical Supply Chain for Clinical Trials in the EU

At IMP Clinical Supply Services Ltd., we are privileged to oversee a crucial aspect of the clinical trial process: the clinical supply chain. The European market presents a unique set of challenges and opportunities for bio-startups, particularly in the realm of clinical trials. Understanding and navigating these complexities is essential for any company looking to […]

Blog
Healthcare Resilience & Clinical Trials in Israel

We would like to share with our clients and colleagues this important letter regarding the priority given to clinical trials in Israel by the MoH. We are always here to assist you in your clinical trial. Feel free to reach out!

Blog
The Use of Direct-to-Patient Methods in Decentralised Clinical Trials in Israel

Abstract: Direct-to-patient (DtP) methods in clinical trials have gained significant attention worldwide as they aim to improve patient access, engagement, and participation in research studies. This paper explores the status of DtP strategies in the context of clinical trials in Israel. It discusses the current landscape, challenges, benefits, and regulatory aspects of DtP initiatives in […]

Contact Us

    Back to top